Anterior Cruciate Ligament (ACL) TearAnterior Cruciate Ligament ReconstructionIsokinetic Test
Study summary
The anterior cruciate ligament (ACL) is the primary structure responsible for controlling anterior-posterior translation and rotational stability of the knee joint. Although ACL reconstruction has long been considered the gold standard among surgical interventions following ACL injury, arthroscopic primary repair techniques have recently regained interest. With advances in minimally invasive surgical procedures, refined patient selection criteria, and improved rehabilitation strategies, the clinical effectiveness of primary repair is once again being re-evaluated. However, there remains a limited body of literature directly comparing the medium- to long-term effects of these two surgical techniques on neuromuscular performance, fatigue tolerance, and functional outcomes.
The aim of this study is to comparatively investigate postoperative muscle strength and endurance, isokinetic fatigue response, muscle oxygenation, proprioception, knee stability, postural control, and patient-reported outcome measures in individuals who have undergone ACL reconstruction or primary repair. Assessments will include low- and high-velocity tests performed on the Cybex Norm isokinetic dynamometer, a 33-repetition fatigue protocol at 300°/s, muscle oxygenation analysis using Train.Red NIRS, knee laxity measurement via the GNRB arthrometer, single-leg balance and landing evaluations using the KFORCE force platform, and subjective outcome measures (IKDC, ACL-RSI).
The findings of this study are expected to provide a more comprehensive understanding of how surgical technique influences physiological, biomechanical, and functional outcomes. This knowledge may contribute to the development of individualized rehabilitation approaches and evidence-based return-to-sport criteria.
Eligibility
Sex
ALL
Min age
18 Years
Max age
40 Years
Healthy volunteers
Accepted
Inclusion Criteria for the ACL Reconstruction Group
* Age 18-40 years
* History of complete ACL rupture treated with ACL reconstruction
* Surgery performed at Gazi University Department of Orthopedics and Traumatology
* At least 12 months postoperative at the time of evaluation
* Ability to comply with all study procedures
* Signed informed consent
Exclusion Criteria for the ACL Reconstruction Group
* Previous surgery for partial or chronic ACL tear
* Concomitant multi-ligament knee injuries
* Prior surgery on the ipsilateral or contralateral knee
* Lower extremity malalignment (e.g., significant varus/valgus)
* Tibial avulsion-type ACL injury
* Neurological or musculoskeletal disorders affecting lower limb function
* Any medical condition that may interfere with test performance or safety
Inclusion Criteria for the Primary ACL Repair Group
* Age 18-40 years
* Complete ACL rupture treated with arthroscopic primary ACL repair
* Surgery performed at Gazi University Department of Orthopedics and Traumatology
* Minimum 12 months postoperative at the time of assessment A-bility to follow and complete study procedures
* Signed informed consent
Exclusion Criteria for the Primary ACL Repair Group
* Previous surgery for partial or chronic ACL injury
* Multi-ligament knee injuries
* History of surgery on either knee
* Lower extremity malalignment
* Tibial avulsion-type ACL rupture
* Neuromuscular or musculoskeletal diseases affecting lower limb function or balance
* Any condition that may affect participation or compromise safety
Inclusion Criteria for the Healthy Control Group
* Age 18-40 years
* No significant lower-extremity malalignment (e.g., varus/valgus deformity)
* No history of lower-extremity injury within the past 12 months
* No known chronic systemic disease
* No history of knee surgery or diagnosed knee pathology
* Ability to understand and comply with study procedures
* Signed informed consent
Exclusion Criteria for the Healthy Control Group
* Presence of clinically significant lower-extremity malalignment
* Lower-extremity musculoskeletal injury within the last 12 months
* Any chronic systemic or metabolic disease
* History of knee injury, knee surgery, or diagnosed knee pathology
* Neurological, vestibular, or musculoskeletal disorder affecting balance or gait
* Inability to complete study procedures
Primary outcome measure(s)
Peak Torque (Isokinetic Strength) — First Day Peak torque of the knee flexor and extensor muscles will be measured using an isokinetic dynamometer (Cybex NORM® isokinetic dynamometer, Humac, CA, USA). Measurements will be performed in the following modes: concentric contraction at 60°/s, eccentric contraction at 60°/s, concentric contraction at 180°/s, and concentric contraction at 300°/s. Peak torque values will be recorded for each testing velocity and contraction mode and expressed in Newton-meters (Nm).
Unit of Measure: Newton-meter (Nm)
Extremity Symmetry Index (ESI) — First day Extremity Symmetry Index will be calculated by comparing the involved and uninvolved limbs using peak torque values obtained from isokinetic testing.
Unit of Measure: Percentage (%)
Conventional Hamstring-to-Quadriceps Ratio (H/Q Ratio) — First day The conventional H/Q ratio will be calculated as the ratio of concentric hamstring peak torque to concentric quadriceps peak torque. Unit of Measure: Ratio
Functional Hamstring-to-Quadriceps Ratio — First day The functional H/Q ratio will be calculated as the ratio of eccentric hamstring peak torque to concentric quadriceps peak torque. Unit of Measure: Ratio
Functional Range — First Day Functional range will be defined as the angular range in which at least 85% of peak torque is maintained during isokinetic testing. Unit of Measure: Percentage (%)
Fatigue-Induced Peak Torque Decline — First Day Fatigue-related performance decline will be calculated as the percentage decrease in peak torque following a 33-repetition isokinetic fatigue protocol at 300°/s. Unit of Measure: Percentage (%)
Muscle Oxygenation — First Day Muscle oxygenation will be assessed using the Train.Red FYER wireless near-infrared spectroscopy (NIRS) system (Train.Red, Gelderland, Netherlands). The device provides continuous, non-invasive measurements of tissue oxygen saturation (StO₂) and the oxy-deoxyhemoglobin difference (HbDiff). Sensors will be placed over the quadriceps and hamstring muscles following SENIAM guidelines. Muscle oxygenation will be recorded before and immediately after the isokinetic fatigue protocol to evaluate changes in local oxygen utilization and metabolic stress.
Trial sites (1)
Facility
City
Region
Status
Gazi University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.